Cytomed Therapeutics Limited (GDTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Sales | 51 | 0 | 0 |
| Gross Profit | 51 | N/A | N/A |
| Operating Expenses | 1,161 | 1,392 | 1,848 |
| Operating Income | -1,111 | -1,392 | -1,848 |
| Interest Expense | 15 | 39 | 93 |
| Other Income | -720 | -1,701 | -394 |
| Pre-tax Income | -1,846 | -3,132 | -2,335 |
| Income Tax | N/A | -1 | 1 |
| Net Income Continuous | -1,846 | -3,132 | -2,336 |
| Minority Interests | -4 | 0 | 0 |
| Net Income | $-1,842 | $-3,133 | $-2,336 |
| EPS Basic Total Ops | -0.16 | -0.29 | -0.30 |
| EPS Basic Continuous Ops | -0.16 | -0.29 | -0.30 |
| EPS Diluted Total Ops | -0.16 | -0.29 | -0.30 |
| EPS Diluted Continuous Ops | -0.16 | -0.29 | -0.30 |
| EPS Diluted Before Non-Recurring Items | -0.16 | -0.29 | -0.30 |
| EBITDA(a) | $-865 | $-1,103 | $-1,554 |